Is a complete CLPT research report available?

No complete published report is available for ClearPoint Neuro, Inc. (CLPT) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ClearPoint Neuro, Inc. (CLPT)

NASDAQ: CLPT · USD

$14.1

-0.39 (-2.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CLPT analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	424.1M
Revenue (ttm)	40.6M
Net income (ttm)	-29.1M
EPS (ttm)	-$1.01
Shares out	30M
Volume	526,222
Beta	1.24
Price target	$28.3	+100.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 40.6M
Net income (ttm): -29.1M
EPS (ttm): -$1.01
Market cap: 424.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CLPT indicators

Market & fundamental data

Available fields

218

Groups with data

Currency

USD

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001285550
Company name	ClearPoint Neuro, Inc.
Country	United States
Country code	US
Cusip	18507C103
Employees	172
Employees Change	57%
Employees Change Percent	49.57
Enterprise value	$452M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	41.91
Industry PE Fwd	19.62
Isin	US18507C1036
Last refreshed	2026-07-30
Market cap	$424.1M
Market cap category	Small-Cap
Price	$14.14
Price currency	USD
Rev Per Employee	236,127.91x
Sector	Healthcare
Sector PE	45.6
Sector PE Fwd	24.3
Sic	3841
Symbol	CLPT
Website	https://www.clearpointneuro.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.85%
EV Sales Forward	8.08x
EV/Sales	11.13x
FCF yield	-6.3%
P/B ratio	22.5x
P/S ratio	10.44x
PS Forward	7.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-65.2%
EBITDA Margin	-63.23%
Gross margin	62.33%
Gross Profit	$25.3M
Gross Profit Growth	28.32%
Gross Profit Growth Q	51.13%
Gross Profit Growth3 Y	23.31%
Gross Profit Growth5 Y	21.53%
Net Income	$-29.1M
Net Income Growth Years	0%
Pretax Margin	-71.46%
Profit Margin	-71.57%
Profit Per Employee	$-168,988
ROA	-24.98
Roa5y	-22.72
ROCE	-31.55
ROE	-149.7
Roe5y	-69.53
ROIC	-29.14

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.54%
Cagr1y	28.92%
Cagr3y	29.97%
Cagr5y	-6.7%
EPS Growth Years	0
Revenue Growth	25.99x
Revenue Growth Q	42.94x
Revenue Growth Quarters	23x
Revenue Growth Years	7x
Revenue Growth3 Y	24.68x
Revenue Growth5 Y	24.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.66
Assets	$93.4M
Cash	$35.6M
Current Assets	$54.9M
Current Liabilities	$9.5M
Debt	$63.6M
Debt Equity	$3.37
Equity	$18.8M
Interest Coverage	-7.02
Liabilities	$74.6M
Long Term Assets	$38.5M
Long Term Liabilities	$65.1M
Net Cash	$-28M
Net Cash By Market Cap	$-6.6
Net Debt Equity	$1.49
Tangible Book Value	$-2.1M
Tangible Book Value Per Share	$-0.07
WACC	10.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.79
Inventory Turnover	2.02
Net Working Capital	$10M
Quick ratio	4.75
Working Capital	$45.4M
Working Capital Turnover	$1.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.27%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	41.54%
1Y total return	28.9%
200-day SMA	14.34
3Y total return	119.57%
50-day SMA	14.97
50-day SMA vs 200-day SMA	50over200
5Y total return	-29.3%
All Time High	200
All Time High Change	-92.93%
All Time High Date	2012-07-03
All Time Low	1.33
All Time Low Change	963.16%
All Time Low Date	2018-12-26
ATR	0.97
Beta	1.24
Beta1y	2.86
Beta2y	1.89
Ch YTD	3.36
High	14.88
High52	30.1
High52 Date	2025-10-09
High52ch	-53.02%
Low	13.83
Low52	8.27
Low52 Date	2026-04-10
Low52ch	70.98%
Ma50ch	-5.53%
Premarket Change Percent	1.24
Premarket Price	$14.71
Premarket Volume	6,792
Price vs 200-day SMA	-1.37%
RSI	39.37
RSI Monthly	51.99
RSI Weekly	51.61
Sharpe ratio	0.68x
Sortino ratio	1.3
Total Return	-4.27%
Tr YTD	3.36
Tr1m	-23.48%
Tr1w	-5.92%
Tr3m	27.62%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	0
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.28
Earnings Revenue Estimate	12,786,664x
Earnings Revenue Estimate Growth	38.76x
Operating Income	$-24.7M
Operating margin	-60.76
Price target	$28.33
Price Target Change	$100

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	26,270,369%
Float Percent	87.6%
Net Borrowing	48,086,000
Shares Insiders	6.06%
Shares Institutions	43.37%
Shares Out	29,989,563
Shares Qo Q	2.42%
Shares Yo Y	4.27%
Short Float	14.07%
Short Ratio	3.67
Short Shares	12.32

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-35.2M
Adjusted OCF	-34,210,000
Average Volume	500,101.85x
Bv Per Share	0.63
CAPEX	$-984,000
Ch10y	41.54
Ch1m	-23.48
Ch1w	-5.92
Ch1y	28.9
Ch3m	27.62
Ch3y	119.6
Ch5y	-29.3
Ch6m	5.29
Change	-2.68%
Change From Open	-1.87
Close	14.53
Days Gap	-0.83
Depreciation Amortization	1,073,000
Dollar Volume	7,440,779.1
Earnings Date	2026-08-03
Earnings Time	amc
EBIT	$-26.5M
EBITDA	$-25.7M
EPS	$-1.01
F Score	3
FCF	$-26.7M
FCF EV Yield	-5.91x
FCF Per Share	$-0.89
Financing CF	49,696,000
Fiscal Year End	December
Founded	1,998
Goodwill	7,472,000
Income Tax	$45,000
Investing CF	153,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Date	2016-07-27
Last Split Type	Reverse
Last10k Filing Date	2026-03-17
Ma150	13.1
Ma150ch	7.98%
Ma20	16.07
Ma20ch	-11.98%
Net CF	24,129,000
Next Earnings Date	2026-08-03
Open	14.41
Optionable	Yes
Position In Range	29.52
Post Close	14.14
Postmarket Change Percent	2.26
Postmarket Price	$14.46
Ppne	16,002,000
Pre Close	14.53
Price Date	2026-07-29
Relative Volume	1.05x
Revenue	40,614,000x
SBC By Revenue	20.9x
Share Based Comp	8,490,000
Tax By Revenue	0.11x
Tr6m	5.29%
Us State	California
Volume	526,222
Z Score	-0.03

ClearPoint Neuro, Inc. (CLPT)

Coverage state: Market snapshot only — no published research

Generate the first CLPT analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · CLPT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CLPT indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CLPT

Frequently asked questions